This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dexcel Ltd.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Sima Volpert: Innovator in Extended Release Formulations
Introduction
Sima Volpert is a notable inventor based in Natania, Israel. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended release medications. Her innovative work has led to the creation of a unique tablet formulation that enhances the delivery of venlafaxine, a medication used to treat depression and anxiety disorders.
Latest Patents
Sima Volpert holds a patent for an "Extended release venlafaxine tablet formulation." This invention features an extended release formulation designed for oral administration in tablet form. The formulation includes a core that contains venlafaxine, a filler, and a water-soluble cellulosic polymer, optionally combined with a water-insoluble cellulosic polymer. The core is coated with a material that consists of a mixture of both types of polymers. The filler is preferably present in an amount of at least about 40% weight per weight of the total formulation, with microcrystalline cellulose being the most preferred filler. The formulation aims to improve the therapeutic efficacy of venlafaxine while ensuring a controlled release of the medication.
Career Highlights
Sima Volpert has dedicated her career to advancing pharmaceutical sciences. Her work at Dexcel Ltd. has positioned her as a key player in the development of innovative drug delivery systems. With her expertise, she has contributed to the enhancement of patient care through improved medication formulations.
Collaborations
Sima has collaborated with Avi Avramoff, a fellow innovator in the field. Their partnership has fostered the development of cutting-edge pharmaceutical solutions that address the needs of patients and healthcare providers alike.
Conclusion
Sima Volpert's contributions to the field of pharmaceutical formulations, particularly her patented extended release venlafaxine tablet, highlight her innovative spirit and dedication to improving healthcare. Her work continues to influence the development of effective medication delivery systems.